SEC Company Response from ABBOTT LABORATORIES (ABT) — Sep 1, 2010
ABBOTT LABORATORIES
Date: Sept. 1, 2010 · CIK: 0000001800 · Accession: 0001104659-10-046958
AI Filing Summary & Sentiment
Referenced dates: August 18, 2010, August 18, 2010
Show Raw Text
CORRESP 1 filename1.htm John A. Berry Abbott Laboratories t 847 938 3591 Divisional Vice President, 100 Abbott Park Road f 847 938 9492 Associate General Counsel Dept. 32L, Bldg. AP6A-2 john.berry@abbott.com and Assistant Secretary Abbott Park, IL 60064-6011 Securities and Benefits September 1, 2010 Rose Zukin Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: Abbott Laboratories Comment Letter Dated August 18, 2010 Dear Ms. Zukin: This letter confirms our conversations of August 29 and August 31, 2010 regarding the deadline for Abbott Laboratories (“Abbott”) to respond to the comment letter from the staff of the Securities and Exchange Commission dated August 18, 2010 (the “Comment Letter”). Abbott is unable to respond to the Comment Letter by September 1, 2010, the date requested by the staff. To respond to the Comment Letter, management needs first to review the response with the Compensation Committee of Abbott’s Board of Directors. We will move that process along expeditiously, and hope to have it completed by September 15, 2010. In the event that despite our efforts we are unable to meet this deadline, we will contact you immediately. If you have any questions, please feel free to contact me at (847) 938-3591. Sincerely, /s/ John A. Berry John A. Berry Divisional Vice President and Associate General Counsel